BMC Cancer, 1471-2407

Tidskrift

Fler filtreringsmöjligheter
  1. 2020
  2. Broadening risk profile in familial colorectal cancer type X; Increased risk for five cancer types in the national Danish cohort

    Christina Therkildsen, Maria Rasmussen, Lars Smith-Hansen, Thomas Kallemose, Lars Joachim Lindberg & Mef Nilbert, 2020 apr 22, I : BMC Cancer. 20, 1, 345.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. EGFR modulates complement activation in head and neck squamous cell carcinoma

    Anas H.A. Abu-Humaidan, Lars Ekblad, Johan Wennerberg & Ole E. Sørensen, 2020 feb 13, I : BMC Cancer. 20, 1, 121.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. 14-type HPV mRNA test in triage of HPV DNA-positive postmenopausal women with normal cytology

    Katrin Christine Asciutto, Christer Borgfeldt & Ola Forslund, 2020, I : BMC Cancer. 20, 1, 1025.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. LGR5 in breast cancer and ductal carcinoma in situ: a diagnostic and prognostic biomarker and a therapeutic target

    Catharina Hagerling, Mark Owyong, Vaishnavi Sitarama, Chih Yang Wang, Charlene Lin, Renske J.E. van den Bijgaart, Charlotte D. Koopman, Audrey Brenot, Ankitha Nanjaraj, Fredrik Wärnberg, Karin Jirström, Ophir D. Klein, Zena Werb & Vicki Plaks, 2020, I : BMC Cancer. 20, 1, 542.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. 2019
  7. A single exercise session improves side-effects of chemotherapy in women with breast cancer: an observational study

    Anna Johnsson, Ingrid Demmelmaier, Katarina Sjövall, Philippe Wagner, Håkan Olsson & Åsa B Tornberg, 2019 nov 8, I : BMC Cancer. 19, s. 1-9 1073.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. A comprehensive approach to rehabilitation interventions following breast cancer treatment - a systematic review of systematic reviews

    U Olsson Möller, I Beck, L Rydén & M Malmström, 2019 maj 20, I : BMC Cancer. 19, 472.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  9. Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): Protocol for a multicenter phase II open label study

    Henrik Jespersen, Roger Olofsson Bagge, Gustav Ullenhag, Ana Carneiro, Hildur Helgadottir, Ingrid Ljuslinder, Max Levin, Charlotta All-Eriksson, Bengt Andersson, Ulrika Stierner, Lisa M. Nilsson, Jonas A. Nilsson & Lars Ny, 2019 maj 2, I : BMC Cancer. 19, 1, 415.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: A meta-analysis

    Shing Fung Lee, Ting Ying Ng & Devon Spika, 2019 apr 11, I : BMC Cancer. 19, 1, 338.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. A novel human in vitro papillomavirus type 16 positive tonsil cancer cell line with high sensitivity to radiation and cisplatin

    Ola Forslund, Natsuki Sugiyama, Chengjun Wu, Naveen Ravi, Yuesheng Jin, Sabine Swoboda, Fredrik Andersson, Davit Bzhalava, Emilie Hultin, Kajsa Paulsson, Joakim Dillner, Stefan Schwartz, Johan Wennerberg & Lars Ekblad, 2019 mar 25, I : BMC Cancer. 19, 1, 265.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. Statin use and breast cancer survival - A Swedish nationwide study

    Signe Borgquist, Per Broberg, Jasaman Tojjar & Håkan Olsson, 2019 jan 11, I : BMC Cancer. 19, 1, 54.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. 2018
  14. Non-linear transformations of age at diagnosis, tumor size, and number of positive lymph nodes in prediction of clinical outcome in breast cancer

    Carina Forsare, Martin Bak, Anna Karin Falck, Dorthe Grabau, Fredrika Killander, Per Malmström, Lisa Rydén, Olle Stål, Marie Sundqvist, Pär Ola Bendahl & Mårten Fernö, 2018 dec 7, I : BMC Cancer. 18, 1, 1226.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. Calcium-activated chloride channel regulator 1 as a prognostic biomarker in pancreatic ductal adenocarcinoma

    Dingyuan Hu, Daniel Ansari, Qimin Zhou, Agata Sasor, Katarzyna Said Hilmersson, Monika Bauden, Yi Jiang & Roland Andersson, 2018 nov 12, I : BMC Cancer. 18, 1, 1 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Chemotherapy-induced peripheral neuropathy: Evidence from genome-wide association studies and replication within multiple myeloma patients

    Seyed Hamidreza Mahmoudpour, Obul Reddy Bandapalli, Miguel Inácio da Silva Filho, Chiara Campo, Kari Hemminki, Hartmut Goldschmidt, Maximilian Merz & Asta Försti, 2018 aug 15, I : BMC Cancer. 18, 1, 820.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Bortezomib prevents cytarabine resistance in MCL, which is characterized by down-regulation of dCK and up-regulation of SPIB resulting in high NF-κB activity

    Catja Freiburghaus, Venera Kuci Emruli, Angelica Johansson, Christian Winther Eskelund, Kirsten Grønbæk, Roger Olsson, Fredrik Ek, Mats Jerkeman & Sara Ek, 2018 apr 25, I : BMC Cancer. 18, 1, 466.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Working to improve the management of sarcoma patients across Europe: A policy checklist

    Bernd Kasper, Estelle Lecointe-Artzner, Suzanne Wait, Shannon Boldon, Roger Wilson, Alessandro Gronchi, Claudia Valverde, Mikael Eriksson, Sarah Dumont, Nora Drove, Athanasia Kanli & Markus Wartenberg, 2018 apr 16, I : BMC Cancer. 18, 1, 424.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. Stellate cells and mesenchymal stem cells in benign mammary stroma are associated with risk factors for breast cancer - an observational study

    Björn Logi Isfoss, Bo Holmqvist, Elin Sand, Johan Forsell, Helena Jernström & Håkan Olsson, 2018 feb 27, I : BMC Cancer. 18, 1, 230.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  20. 2017
  21. High blood glucose levels are associated with higher risk of colon cancer in men: A cohort study

    Alexandra Vulcan, Jonas Manjer & Bodil Ohlsson, 2017 dec 12, I : BMC Cancer. 17, 1, 842.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma

    Monika Bauden, Theresa Kristl, Agata Sasor, Bodil Andersson, György Marko-Varga, Roland Andersson & Daniel Ansari, 2017 dec 2, I : BMC Cancer. 17, 1, 810.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. Smoking and alcohol cessation intervention in relation to radical cystectomy: A qualitative study of cancer patients' experiences

    Susanne Vahr Lauridsen, Thordis Thomsen, Gudrun Kaldan, Line Noes Lydom & Hanne Tønnesen, 2017 nov 25, I : BMC Cancer. 17, 1, 793.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Cerebellar mutism syndrome in children with brain tumours of the posterior fossa

    Morten Wibroe, Johan Cappelen, Charlotte Castor, Niels Clausen, Pernilla Grillner, Thora Gudrunardottir, Ramneek Gupta, Bengt Gustavsson, Mats Heyman, Stefan Holm, Atte Karppinen, Camilla Klausen, Tuula Lönnqvist, René Mathiasen, Pelle Nilsson, Karsten Nysom, Karin Persson, Olof Rask, Kjeld Schmiegelow, Astrid Sehested & 4 andra, Harald Thomassen, Ingrid Tonning-Olsson, Barbara Zetterqvist & Marianne Juhler, 2017 jun 21, I : BMC Cancer. 17, 1, 439.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. Design of a randomized controlled trial of physical training and cancer (Phys-Can) - the impact of exercise intensity on cancer related fatigue, quality of life and disease outcome

    Sveinung Berntsen, Neil K. Aaronson, Laurien Buffart, Sussanne Börjeson, Ingrid Demmelmaier, Maria Hellbom, Pernille Hojman, Helena Igelström, Birgitta Johansson, Ronnie Pingel, Truls Raastad, Galina Velikova, Pernilla Åsenlöf & Karin Nordin, 2017 mar 27, I : BMC Cancer. 17, 1, s. 1-12 218.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. Life tables for global surveillance of cancer survival (the CONCORD programme): Data sources and methods

    Devon Spika, Finian Bannon, Audrey Bonaventure, Laura M. Woods, Rhea Harewood, Helena Carreira, Michel P. Coleman & Claudia Allemani, 2017 feb 27, I : BMC Cancer. 17, 1, 159.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: A nationwide cohort study

    Huan Song, Fang Fang, Unnur Valdimarsdóttir, Donghao Lu, Therese M L Andersson, Christina Hultman, Weimi Ye, Lars Lundell, Jan Johansson, Magnus Nilsson & Mats Lindblad, 2017 jan 3, I : BMC Cancer. 17, 1, 2.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: The randomized controlled SENOMAC trial

    Jana de Boniface, Jan Frisell, Yvette Andersson, Leif Bergkvist, Johan Ahlgren, Lisa Rydén, Roger Olofsson Bagge, Malin Sund, Hemming Johansson, Dan Lundstedt & on behalf of the SENOMAC Trialists' Group on behalf of the SENOMAC Trialists' Group, 2017, I : BMC Cancer. 17, 1, 379.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  29. 2016
  30. ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer

    Kristina Magnusson, Gabriela Gremel, Lisa Rydén, Victor Pontén, Mathias Uhlén, Anna Dimberg, Karin Jirström & Fredrik Pontén, 2016 nov 18, I : BMC Cancer. 16, 1, 904.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. The expression pattern of matrix-producing tumor stroma is of prognostic importance in breast cancer

    Sofia Winslow, Kajsa Ericson Lindquist, Anders Edsjö & Christer Larsson, 2016 nov 4, I : BMC Cancer. 16, 1, 841.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer

    Johanna S M Mattsson, Hans Brunnström, Verena Jabs, Karolina Edlund, Karin Jirström, Stephanie Mindus, Linnéa la Fleur, Fredrik Pontén, Mats G. Karlsson, Christina Karlsson, Hirsh Koyi, Eva Brandén, Johan Botling, Gisela Helenius, Patrick Micke & Maria A. Svensson, 2016 aug 5, I : BMC Cancer. 16, 1, 603.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  33. Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer

    Qing Bai She, Sofia Gruvberger, Matthew Maurer, Yilun Chen, Mervi Jumppanen, Tao Su, Meaghan Dendy, Ying Ka Ingar Lau, Lorenzo Memeo, Hugo M. Horlings, Marc J. van de Vijver, Jorma Isola, Hanina Hibshoosh, Neal Rosen, Ramon Parsons & Lao H. Saal, 2016 aug 2, I : BMC Cancer. 16, 1, 587.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. The eicosanoids leukotriene D4 and prostaglandin E2 promote the tumorigenicity of colon cancer-initiating cells in a xenograft mouse model

    Kishan Bellamkonda, Naveen Kumar Chandrashekar, Janina Osman, Benson Chellakkan Selvanesan, Sayeh Savari & Anita Sjölander, 2016 jul 7, I : BMC Cancer. 16, 1, 425.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population.

    Chaymaa Marouf, Stella Göhler, Miguel Inacio Da Silva Filho, Omar Hajji, Kari Hemminki, Sellama Nadifi & Asta Försti, 2016, I : BMC Cancer. 16, 1, 165.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  36. Breast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogs.

    Xiaoli Huang, Björn Borgström, Sebastian Kempengren, Lo Persson, Cecilia Hegardt, Daniel Strand & Stina Oredsson, 2016, I : BMC Cancer. 16, 1, 145.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. CYP1A2 - a novel genetic marker for early aromatase inhibitor response in the treatment of breast cancer patients

    Maria Simonsson, Srinivas Veerla, Andrea Markkula, Carsten Rose, Christian Ingvar & Helena Jernström, 2016, I : BMC Cancer. 16, 1, 256.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. Runs of homozygosity and inbreeding in thyroid cancer

    Hauke Thomsen, Bowang Chen, Gisella Figlioli, Rossella Elisei, Cristina Romei, Monica Cipollini, Alfonso Cristaudo, Franco Bambi, Per Hoffmann, Stefan Herms, Stefano Landi, Kari Hemminki, Federica Gemignani & Asta Försti, 2016, I : BMC Cancer. 16, 1, 227.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  39. 2015
  40. Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling

    Jasna Bancovik, Dayson F Moreira, Daniel Carrasco, Jun Yao, Dale Porter, Ricardo Moura, Anamaria Camargo, Cibely C Fontes-Oliveira, Miguel G Malpartida, Silvia Carambula, Edouard Vannier, Bryan E Strauss, Alda Wakamatsu, Venancio AF Alves, Angela F Logullo, Fernando A Soares, Kornelia Polyak & José E. Belizário, 2015 feb 19, I : BMC Cancer. 15, s. 70

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  41. DNA methylation and histone modifications regulate SOX11 expression in lymphoid and solid cancer cells.

    Lena Nordström, Elin Andersson, Venera Kuci, Elin Gustavsson, Karolina Holm, Markus Ringnér, Per Guldberg & Sara Ek, 2015, I : BMC Cancer. 15, 1, 273.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. Early diagnostic value of Bcl-3 localization in colorectal cancer.

    Karunakar Saamarthy, Sofie Björner, Martin Johansson, Göran Landberg, Ramin Massoumi, Karin Jirström & Katarzyna Masoumi, 2015, I : BMC Cancer. 15, 1, 341.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. Effects of statin use on volumetric mammographic density: results from the KARMA study.

    Ida Skarping, Judith S Brand, Per Hall & Signe Borgquist, 2015, I : BMC Cancer. 15, 1, 435.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  44. The human complement inhibitor Sushi Domain-Containing Protein 4 (SUSD4) expression in tumor cells and infiltrating T cells is associated with better prognosis of breast cancer patients.

    Emelie Englund, Bart Reitsma, Ben King, Astrid Escudero Esparza, Sioned Owen, Akira Orimo, Marcin Okroj, Theano Anagnostaki, Wen G Jiang, Karin Jirström & Anna Blom, 2015, I : BMC Cancer. 15, 737.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  45. The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study.

    Signe Borgquist, Wenjing Zhou, Karin Jirström, Rose-Marie Amini, Thomas Sollie, Therese Sørlie, Carl Blomqvist, Salma Butt & Fredrik Wärnberg, 2015, I : BMC Cancer. 15, 468.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. 2014
  47. Causes of death in patients with extranodal cancer of unknown primary: searching for the primary site

    Matias Riihimäki, Akseli Hemminki, Kristina Sundquist & Kari Hemminki, 2014, I : BMC Cancer. 14, 439.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  48. Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response.

    Sophie Lehn, Nicholas P Tobin, Andrew H Sims, Olle Stål, Karin Jirström, Håkan Axelson & Göran Landberg, 2014, I : BMC Cancer. 14, 1, 119.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  49. Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)

    Kristina Lindemann, Susanne Malander, Rene D. Christensen, Mansoor R. Mirza, Gunnar B. Kristensen, Elisabeth Aavall-Lundqvist, Ignace Vergote, Per Rosenberg, Karin Boman & Britta Nordstrom, 2014, I : BMC Cancer. 14, 68.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  50. Expression of miR-34c induces G2/M cell cycle arrest in breast cancer cells

    Chandrani Achari, Sofia Winslow, Yvonne Ceder & Christer Larsson, 2014, I : BMC Cancer. 14, 538.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  51. IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort.

    Andrea Markkula, Maria Simonsson, Christian Ingvar, Carsten Rose & Helena Jernström, 2014, I : BMC Cancer. 14, 759.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  52. Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580 000 subjects within the Me-Can project

    Bjorn Lindkvist, Dorthe Johansen, Tanja Stocks, Hans Concin, Tone Bjorge, Martin Almquist, Christel Haggstrom, Anders Engeland, Goran Hallmans, Gabriele Nagel, Hakan Jonsson, Randi Selmer, Hanno Ulmer, Steinar Tretli, Par Stattin & Jonas Manjer, 2014, I : BMC Cancer. 14, 103.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  53. Repeat polymorphisms in ESR2 and AR and colorectal cancer risk and prognosis: results from a German population-based case-control study

    Anja Rudolph, Hong Shi, Asta Försti, Michael Hoffmeister, Juan Sainz, Lina Jansen, Kari Hemminki, Hermann Brenner & Jenny Chang-Claude, 2014, I : BMC Cancer. 14, 817.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  54. T3 levels in relation to prognostic factors in breast cancer: a population-based prospective cohort study

    Ada Tosovic, Anne-Greth Bondeson, Lennart Bondeson, Ulla-Britt Ericsson & Jonas Manjer, 2014, I : BMC Cancer. 14, 536.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  55. TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative group

    Charlotte Levin Tykjær Jørgensen, Christina Bjerre, Bent Ejlertsen, Karsten D. Bjerre, Eva Balslev, Annette Bartels, Nils Brünner & Dorte Lisbet Nielsen, 2014, I : BMC Cancer. 14, 360.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  56. 2013
  57. Automatic registration of multi-modal microscopy images for integrative analysis of prostate tissue sections

    Giuseppe Lippolis, Anders Edsjö, Leszek Helczynski, Anders Bjartell & Niels Christian Overgaard, 2013, I : BMC Cancer. 13, s. 408-418

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  58. Cell-line-specific stimulation of tumor cell aggressiveness by wound healing factors - a central role for STAT3

    Lars Ekblad, Gustaf Lindgren, Emma Persson, Elisabeth Kjellén & Johan Wennerberg, 2013, I : BMC Cancer. 13, 33.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  59. Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer

    Matias Riihimäki, Hauke Thomsen, Akseli Hemminki, Kristina Sundquist & Kari Hemminki, 2013, I : BMC Cancer. 13

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  60. Forced expression of the DEK-NUP214 fusion protein promotes proliferation dependent on upregulation of mTOR

    Carl Sandén, Malin Ageberg, Jessica Petersson, Andreas Lennartsson & Urban Gullberg, 2013, I : BMC Cancer. 13, 440.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  61. Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine

    Charlotte Levin Tykjaer Jörgensen, Bent Ejlertsen, Karsten D. Bjerre, Eva Balslev, Dorte Lisbet Nielsen & Kirsten V Nielsen, 2013, I : BMC Cancer. 13, 541.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  62. Metformin-mediated growth inhibition involves suppression of the IGF-I receptor signalling pathway in human pancreatic cancer cells.

    Emelie Karnevi, Katarzyna Said Hilmersson, Roland Andersson & Ann Rosendahl, 2013, I : BMC Cancer. 13, May,10, 235.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  63. Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study

    Wenjing Zhou, Karin Jirström, Rose-Marie Amini, Marie-Louise Fjallskog, Thomas Sollie, Henrik Lindman, Therese Sorlie, Carl Blomqvist & Fredrik Warnberg, 2013, I : BMC Cancer. 13, 512.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  64. NOTCH1 mutations influence survival in chronic lymphocytic leukemia patients

    Kerstin Willander, Ravi Kumar Dutta, Jonas Ungerback, Rebeqa Gunnarsson, Gunnar Juliusson, Mats Fredrikson, Mats Linderholm & Peter Soderkvist, 2013, I : BMC Cancer. 13, 274.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  65. Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer

    Patrick C. O'Leary, Sarah A. Penny, Roisin T. Dolan, Catherine M. Kelly, Stephen F. Madden, Elton Rexhepaj, Donal J. Brennan, Amanda H. McCann, Fredrik Ponten, Mathias Uhlen, Radoslaw Zagozdzon, Michael J. Duffy, Malcolm R. Kell, Karin Jirström & William M. Gallagher, 2013, I : BMC Cancer. 13

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  66. The cysteinyl leukotriene 2 receptor contributes to all-trans retinoic acid-induced differentiation of colon cancer cells

    Astrid Bengtsson, Gunilla Jönsson, Cecilia Magnusson, Tavga Salim, Cecilia Axelsson & Anita Sjölander, 2013, I : BMC Cancer. 13, 336.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  67. Variants at the 9p21 locus and melanoma risk

    Livia Maccioni, Panduranga Sivaramakrishna Rachakonda, Justo Lorenzo Bermejo, Dolores Planelles, Celia Requena, Kari Hemminki, Eduardo Nagore & Rajiv Kumar, 2013, I : BMC Cancer. 13, 325.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  68. 2012
  69. Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study

    Anna-Karin Falck, Pär-Ola Bendahl, Christian Ingvar, Jorma Isola, Per-Ebbe Jönsson, Pia Lindblom, Kristina Lövgren, Karin Rennstam, Mårten Fernö & Lisa Rydén, 2012, I : BMC Cancer. 12

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  70. Expanded clinical and experimental use of SOX11-using a monoclonal antibody

    Lena Nordström, Ulrika Andreasson, Mats Jerkeman, Michael Dictor, Carl Borrebaeck & Sara Ek, 2012, I : BMC Cancer. 12, 269

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  71. Identification of BIRC6 as a novel intervention target for neuroblastoma therapy

    Fieke Lamers, Linda Schild, Jan Koster, Frank Speleman, Ingrid Øra, Ellen M. Westerhout, Peter van Sluis, Rogier Versteeg, Huib N. Caron & Jan J. Molenaar, 2012, I : BMC Cancer. 12

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  72. Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study

    Josef Thaler, Meinolf Karthaus, Laurent Mineur, Richard Greil, Henry Letocha, Ralf Hofheinz, Eva Fernebro, Erick Gamelin, Ana Banos & Claus-Henning Koehne, 2012, I : BMC Cancer. 12, 438

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift